Current Status in the Surgery and Conservative Management of Upper Urinary System Tumors
Journal Title: Üroonkoloji Bülteni - Year 2018, Vol 17, Issue 4
Abstract
Upper urinary tract urothelial cancers constitute 5% of all urothelial cancers and standard therapy is bladder cuff excision with nephroureterectomy. This treatment is performed as open or technologically assisted (laparoscopic and robotic) surgery. Conservative treatment approaches include endoscopic treatments, segmental resection, and upper urinary tract immunotherapy. Upper urinary tract immunotherapy is considered effective in patients with carcinoma in situ. In addition, the development of targeted molecules and gene therapies is also anticipated. In selected patient groups, endoscopic (antegrade percutaneous and retrograde ureteroscopic) procedures are being implemented as an alternative to nephroureterectomy in order to prevent unnecessary organ loss and to preserve the nephrons. Oncological survival and tumor control with the endoscopic approach are similar to the outcomes of radical surgery in cases with low-stage and grade tumors. Advantages of the endoscopic approach include minimal morbidity and preservation of kidney function, while disadvantages include life-long follow-up and the need for a large number of endoscopies. In cases with a large tumor burden, the retrograde ureteroscopic approach is generally preferred instead of percutaneous treatment.
Authors and Affiliations
Serdar Geyik
Keywords
Related Articles
- EP ID EP437629
- DOI 10.4274/uob.1119
- Views 103
- Downloads 0
Does the Future of Prostate Cancer Treatment Lie with Apoptotic Inducers?
Despite present-day clinical achievements which can extend the overall survival period, prostate cancer (PCa) related mortality remains a major problem. Resistance against apoptosis which consequently leads to disease pr...
Is Preoperative Neutrophil Lymphocyte Ratio a Reliable Prognostic Parameter for Localized Prostate Cancer?
Objective In spite of all efforts, prostate cancer is still the 2nd highest cause of cancer-related deaths in men. For this reason new developments are needed in diagnosis, treatment and follow-up of prostate cancer. Neu...
The Diagnostic and Prognostic Significance of MicroRNA-21 in Non-muscle Invasive Bladder Tumors
Bladder cancer (BC) is one of the commonly diagnosed urological cancers that causes human death, ranked as the seventh most common cancer worldwide. To date, no reliable diagnostic tool has been defined to recognize non-...
Early and Late Complications of Urinary Diversions after Radical Cystectomy
One of the strongest predictive factors for the early and late postoperative complications and morbidity of radical cystectomy is the type of urinary diversion following cystectomy. In this paper, we reviewed English-lan...
Incidental Amyloidosis of the Seminal Vesicle: A Case Report and Review of the Literature
With a widely usage of prostate specific antigen (PSA) testing as a screening tool, number of prostate biopsy procedures and number of biopsy cores are increased because of the negative pathology results. As a result of...